Media Hub

Latest Press Releases

• Innate Pharma to participate in a bladder cancer panel at the BTIG Virtual Biotechnology Conference

  July 23, 2026

• Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)

  July 21, 2026

• Outcome of Innate Pharma’s 2026 Annual General Meeting

  May 22, 2026

Selected media

• Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma

  Mon, 12/09/2024 - 00:00

  • Read more about Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma